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Abstract
Background: Abnormal trophoblast differentiation and function is the basis of many placenta-based pregnancy disorders,
including pre-eclampsia and fetal growth restriction. PPARc, a ligand-activated nuclear receptor, plays essential roles in
placental development; null murine embryos die at midgestation due to abnormalities in all placental layers, in particular,
small labyrinth and expanded giant cell layer. Previous studies have focused mostly on the role of PPARc in trophoblast
invasion. Based on the previously reported role of PPARc in preadipocyte differentiation, we hypothesized that PPARc also
plays a pivotal role in trophoblast differentiation. To test this hypothesis, we report derivation of wild-type and PPARc-null
trophoblast stem (TS) cells.
Methodology/Principal Findings: PPARc-null TS cells showed defects in both proliferation and differentiation, specifically
into labyrinthine trophoblast. Detailed marker analysis and functional studies revealed reduced differentiation of all three
labyrinthine lineages, and enhanced giant cell differentiation, particularly the invasive subtypes. In addition, rosiglitazone, a
specific PPARc agonist, reduced giant cell differentiation, while inducing Gcm1, a key regulator in labyrinth. Finally,
reintroducing PPARc into null TS cells, using an adenovirus, normalized invasion and partially reversed defective
labyrinthine differentiation, as assessed both by morphology and marker analysis.
Conclusions/Significance: In addition to regulating trophoblast invasion, PPARc plays a predominant role in differentiation
of labyrinthine trophoblast lineages, which, along with fetal endothelium, form the vascular exchange interface with
maternal blood. Elucidating cellular and molecular mechanisms mediating PPARc action will help determine if modulating
PPARc activity, for which clinical pharmacologic agonists already exist, might modify the course of pregnancy disorders
associated with placental dysfunction.
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Introduction
Placental dysfunction, caused by abnormalities in trophoblast
differentiation and function, is associated with many pregnancy
disorders, including intrauterine growth restriction and pre-
eclampsia [reviewed in 1]. Peroxisome proliferator-activated
receptors (PPARs), which are transcription factors and mem-
bers of the ligand-activated nuclear hormone receptor super-
family, play major roles in diverse aspects of energy metabolism,
inflammation, and development [2–5]. Following ligand
binding, PPARs form heterodimers with retinoid X receptors
(RXRs), and bind to PPAR-response elements (PPREs) of target
genes to activate transcription [2]. PPARc has received much
attention with regard to its role in adipogenesis and energy
metabolism, including its highly efficacious synthetic ligands,
the thiazolidinediones, which are routinely used clinically for
treatment of type 2 diabetes [3,4]. However, genetically null
mice revealed a surprising role for PPARc: namely its essential
role in placental development [6,7]. Since this discovery,
additional studies have focused primarily on the effect of
PPARc ligands in human trophoblast, revealing effects on both
syncytiotrophoblast function [8] and trophoblast invasion [9].
Further studies in mice have identified some transcriptional
targets of PPARc in trophoblast [10] and shown that treatment
of pregnant mothers with PPARc agonists led to fetal and
placental growth restriction in a PPARc-dependent manner
[11]. However, specific cellular and molecular mechanisms by
which this important transcription factor exerts its predominate
role in trophoblast differentiation and placental development
have not been elucidated.
Given the essential role of PPARc in adipocyte differenti-
ation [12,13], and the abnormalities observed in specific layers
of PPARc-null placentas, we hypothesized that PPARc also
regulates critical aspects of normal trophoblast differentiation.
In order to test this hypothesis, we generated both wild-type
(WT) and PPARc-null trophoblast stem (TS) cells, from E3.5
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e8055murine blastocysts using previously published methods [14].
Murine TS cells are an invaluable tool for characterizing
the role of specific genes in trophoblast differentiation and
function [15–17]. In this study, we characterized cellular
properties and the differentiation capacity of PPARc-null
TS cells and found a predominate role for this protein in
both trophoblast proliferation and labyrinthine trophoblast
differentiation.
Results
PPARc
2/2 TS Cells Grow Slower than Their Wild-Type
Counterparts
PPARc
+/+ and PPARc
2/2 TS cells were generated from E3.5
blastocysts from two heterozygous matings. Two PPARc
+/+, one
PPARc
+/2, and three PPARc
2/2 TS cell lines were obtained from
14 explanted blastocysts (43% overall yield). Both PPARc
+/+ and
two PPARc
2/2 TS cell lines were chosen for further study. Both
wild-type (WT) lines were analyzed in most experimentsand didnot
show statistically significant differences. Results from one WT line
are shown for simplicity. TS cell genotypes, determined by PCR of
genomic DNA, were confirmed at the phenotypic expression level
using RT-PCR of total cell RNA with primers surrounding exon 3,
which is deleted in the null allele (Figure 1A), and by Western blot
(Figure 1D). Both WT and null lines expressed markers of
trophectoderm (Cdx-2, Eomes, Errb; see Table 1 for definitions
of gene abbreviations),and lacked inner cell mass (ICM)/embryonic
stem (ES) cell markers (Oct3/4) (Figure 1B, and data not shown). In
WT TS cell cultures, PPARc mRNA and protein were detected at
very low levels in the undifferentiated state, but were strongly
upregulated upon differentiation, with maximal expression ob-
servedat day4 (Figures 1Cand 1D). In contrast PPARc proteinwas
not detected in PPARc
2/2 TS cell cultures at any stage of
differentiation (Figure 1D). In addition, while levels of PPARa were
comparable between WT and null TS cells, PPARb/d was
upregulated (1.5–2.5 fold by densitometry, normalized to bactin
expression) in differentiated null cells compared to PPARc
+/+ cells
(Figure 1D); these changes in PPARa and PPARb/d protein levels
were reflective of changes in their respective mRNA levels (data not
shown).
Morphologically, both WT and null cells formed typical
undifferentiated colonies when grown in TSMFH media
(standard TS cell growth media; see Materials and Methods),
a n dd i f f e r e n t i a t e dt of o r mt r o p h oblast giant cells (TGC’s) when
switched to TS media (differentiation media: withdrawal of
conditioned media, FGF4 and heparin) (see below). However,
both PPARc
2/2 lines in TSMFH media grew more slowly (1.5–
3-fold) than WT TS cells (Figure 2A) such that expansion of
PPARc
2/2,b u tn o tP P A R c
+/+ cultures was similar under
growth and differentiation conditions (Figure 2B). To examine
stem cells more directly, and to assess whether slow overall
growth in PPARc
2/2 cultures was due to accumulation and
carry-over of post-mitotic giant cells during passage, we lightly
trypsinized both PPARc
+/+ and PPARc
2/2 cultures (selectively
releasing undifferentiated cells), plated the resultant nonadher-
ent, stem cell enriched populations at equivalent densities (10
5
cells per well in a 6-well plate) and assessed growth and
morphologic differentiation in TSMFH media over a 3-day
period (Figure 3). The ratio of giant cells to undifferentiated
(stem) cells was initially similar in PPARc
+/+ and PPARc
2/2
cultures, but increased significantly over time only in the latter
(Figure 3B). This indicates that absence of PPARc leads to
Figure 1. Derivation of PPARc
+/+ and PPARc
2/2 TS cells. A) Confirmation of wild-type and null genotypes, using RT-PCR with primers flanking
the deleted exon 3 in the PPARc1 gene. Arrows indicate the position of primers used for PCR. B) Both WT and null TS cells express the trophectoderm
marker Cdx2, but not ICM-specific Oct3/4, which is limited to ES cells. C) PPARc mRNA expression in WT TS cells peaks at day 4 of differentiation,
based on quantitative RT-PCR. D) Western blot for PPARc, PPARa, and PPARb/d, in WT and null TS cells.
doi:10.1371/journal.pone.0008055.g001
PPARc in Trophoblast
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g i a n tc e l l se v e ni nt h ep r e s e n c eo fM E F - c o n d i t i o n e dm e d i u m ,
FGF4 and heparin. Differentiation of syncytiotrophoblast under
these conditions was negligible in both PPARc
+/+ and PPARc
2/2
cultures, with no significant difference between the two cell types
(Figure 3C).
PPARc
2/2 TS Cells Exhibit Altered Trophoblast Lineage
Differentiation In Vitro
We differentiated both WT and null cells for 7-days and
assessed labyrinthine (syncytiotrophoblastic) and invasive tro-
phoblast/giant cell differentiation both by morphology and
qRT-PCR. Morphologic differentiation was assessed by double
staining with phalloidin and DAPI to distinguish giant cells, with
one or twolargenuclei (each at least double the size of a stem cell
nucleus) from multi-nucleated syncytiotrophoblast (three or
more nuclei each equivalent in size to stem cell nuclei).
Morphologic analyses revealed that syncytiotrophoblasts were
significantly less abundant in differentiated PPARc
2/2 than in
PPARc
+/+ TS cells (4.760.7% vs. 7.361.0%, respectively,
P=0.023)(Figure4).
In preliminary experiments, differentiating WT and PPARc
2/2
cells were analyzed daily for 7 days by qRT-PCR to determine the
time of maximal expression of each lineage marker. The results
were similar to previously published data, indicating maximal
expression of Gcm1 at day 1, spongiotrophoblast and labyrinthine
markers at day 4, and giant cell markers and muc1 at day 7 of
differentiation [10,17,18 , and data not shown]. For the remaining
experiments, these time points were used to determine differences
in marker expression, although additional days of differentiation
were also frequently examined to avoid misinterpretation due to
minor alteration in expression kinetics. Compared to PPARc
+/+
Table 1. List of primers.
Gene abbreviation Gene Name Primer sequence
Errb Estrogen-related receptor-b F5 9 GGGAGCTTGTGTTCCTCATC 39
R5 9 CTACCAGGCGAGAGTGTTCC 39
Cdx2 Caudal type homeobox-2 F 59 CCAGCTCTTTGCCTCTCTGT 39
R5 9 TGCCTCTGGCTCCTGTAGTT 39
Oct3/4 (Pou5f1) POU domain transcription factor-1 F 59 GCCGTGAAGTTGGAGAAGGT 39
R5 9 GAAGCGACAGATGGTGGTCT 39
Pl-I Placental lactogen-1 F 59 TGGTGTCAAGCCTACTCCTTT 39
R5 9 CAGGGGAAGTGTTCTGTCTGT 39
Pl-II Placental lactogen-2 F 59 CCAACGTGTGATTGTGGTGT 39
R5 9 TCTTCCGATGTTGTCTGGTG 39
Tpbpa (4311) Trophoblast specific protein alpha F 59 CGGAAGGCTCCAACATAGAA 39
R5 9 TCAAATTCAGGGTCATCAACAA 39
synA Syncytin-A F 59 CCCTTGTTCCTCTGCCTACTC 39
R5 9 TCATGGGTGTCTCTGTCCAA 39
Gcm1 Glial cells missing-1 F 59 AACACCAACAACCACAACTCC 39
R5 9 CAGCTTTTCCTCTGCTGCTT 39
muc1 Mucin 1 F 59 TTGGTTGCTTTGGCTATCGT 39
R5 9 TTACCTGCCGAAACCTCCTC 39
Tfeb Transcription factor EB F 59 AACAAAGGCACCATCCTCAA 39
R5 9 CAGCTCGGCCATATTCACAC 39
Ctsq Cathepsin Q F 59 AACTAAAGGCCCCATTGCTAC 39
R5 9 CAATCCCCATCGTCTACCC 39
Plf Proliferin F 59 TGAGGAATGGTCGTTGCTTT 39
R5 9 TCTCATGGGGCTTTTGTCTC 39
PPARc (qRT-PCR) Peroxisome proliferator activated receptor gamma F 59 GACAGGAAAGACAACGGACAA 39
R5 9 AAACTGGCACCCTTGAAAAA 39
PPARc (genotyping) Peroxisome proliferator activated receptor gamma F 59 GAGCTGACCCAATGGTTGCTGATT 39
R5 9 GCATTATGAGACATCCCC 39
PPARa Peroxisome proliferator activated receptor alpha F 59 ACACCCTCTCTCCAGCTTCC 39
R5 9 AATCTTGCAGCTCCGATCAC 39
PPARb/d Peroxisome proliferator activated receptor delta F 59 CGGGAAGAGGAGAAAGAGGA 39
R5 9 GTGGACCCCGTAGTGGAAG 39
18S 18S ribosomal subunit F 59 CGCGGTTCTATTTTGTTGGT 39
R5 9 AACCTCCGACTTTCGTTCTTG 39
doi:10.1371/journal.pone.0008055.t001
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2/2 TS cells grow slower than their WT counterparts. MTT assay comparing A) WT and null TS cell growth over a 5 day period
in TSMFH medium (note: standard deviations are too small to observe for WT and Null-1 data) or B) WT and null TS cell growth in TSMFH (growth) vs.
TS (differentiation) medium. Arrow in B shows the point at which the indicated cultures were switched from TSMFH to TS medium.
doi:10.1371/journal.pone.0008055.g002
Figure 3. PPARc
2/2 TS cells prematurely differentiate into giant cells. A) PPARc
2/2 TS cells show fewer undifferentiated colonies (arrows)
than WT TS cells when cultured in TSMFH medium. Cells are double-stained with phalloidin (red) and DAPI (blue). B and C) Quantitation of
trophoblast giant cell (TGC) (B) and syncytiotrophoblast (STB) (C) differentiation, assessed by morphology as in panel A and described in the legend
to Figure 4, in WT and null TS cells grown for 3 days in TSMFH media. 200–300 cells were counted for each time point in each of three independent
experiments.
doi:10.1371/journal.pone.0008055.g003
PPARc in Trophoblast
PLoS ONE | www.plosone.org 4 November 2009 | Volume 4 | Issue 11 | e8055TS cells, PPARc
2/2 cells showed increased spongiotrophoblast
(Tpbpa) and TGC (Pl-I, Pl-II) differentiation (Figure 5), and
decreased labyrinthine/syncytiotrophoblast (Gcm1, syncytin A,
muc1, Tfeb) differentiation (Figure 6), by marker analysis.
The striking downregulation of Gcm1 (Figure 6), an early
marker and essential determinant of syncytiotrophoblast layer II
(SynT-II) differentiation in the placental labyrinth, as well as
markers further downstream in labyrinthine/syncytiotrophoblast
differentiation (syncytin A, expressed in syncytiotrophoblast layer
I/SynT-I labyrinthine cells, and muc1), in the absence of PPARc,
is consistent with the decreased number of multinucleated
syncytiotrophoblast in differentiated PPARc
2/2 TS cells
(Figure 4) [19].
PPARc
2/2 TS Cells Differentiate Preferentially into
Invasive Subtypes of Trophoblast Giant Cells
Recently, Simmons et al. [20] characterized diverse subtypes
of trophoblast giant cells (TGC) based on expression of specific
markers, including Pl-I, Pl-II, Plf, and Ctsq, and showed that
formation of these subtypes by TS cells is differentially
regulated in vitro.S p e c i f i c a l l y ,C t s qi sam a r k e ro fs i n u s o i d a l
TGC, likely derived from chorion-proximal Tpbpa
2 precursors
in ectoplacental cone (EPC) and participating in labyrinth
formation, while Plf is present in canal-type, spiral artery-
associated, and parietal TGC, likely derived primarily from
chorion-distal Tpbpa
+ EPC [19,20]. In addition to upregulation
of Pl-I and Pl-II (30-fold and 3.5-fold, respectively, Figure 5), we
also found that Plf is upregulated ,4-fold while Ctsq is
downregulated ,3-fold in differentiated PPARc
2/2 compared
to WT TS cells (Figure 7A). This suggests that PPARc
2/2 TS
cells preferentially differentiate to invasive trophoblast sub-
types, including canal-type and parietal TGC, and do not
readily form sinusoidal TGC, an important constituent of
chorion and fully differentiated labyrinth [19]. To determine
whether the functional capacity of PPARc
2/2 TS cells mirrors
their altered expression profile of TGC genes, we compared the
behavior of PPARc
+/+ and PPARc
2/2 TS cells, differentiated
for 7 days, in a Matrigel invasion assay. As previously described
[21], the majority of cells invading Matrigel were morpholog-
ically consistent with TGC (arrowheads in Figure 7B). In
addition, although similar numbers of WT and PPARc
2/2
differentiatedTGCwereappliedtothemembrane(seeFigure4;
,92,700 TGC in wild-type vs. ,95,200 TGC in null cells after
7 days of differentiation), over two-fold more PPARc
2/2 TGC
invaded to the far side of the Matrigel membrane compared
to their WT counterparts (Figure 7C), consistent with an
enhanced invasive capacity of individual TGC in the absence of
PPARc.
Rosiglitazone Inhibits Trophoblast Giant-Cell
Differentiation and Invasion in a PPARc-Dependent
Manner
To determine the effects of pharmacologic activation of
PPARc on trophoblast, we tested the ability of rosiglitazone, a
specific PPARc agonist, to alter TS cell proliferation and
differentiation in vitro. While TS cell proliferation was not altered
(data not shown), expression of differentiation markers (Figures 8
and 9) was differentially regulated by treatment of PPARc
+/+ TS
cells, but not PPARc
2/2 TS cells, with 1 mM rosiglitazone.
Specifically, while rosiglitazone decreased expression of the
spongiotrophoblast marker Tpbpa (2.2 fold, P=0.0287) and
giant cell markers Pl-I (5 fold, P=0.0025) and Pl-II (11 fold,
P=0.0183;), the labyrinthine markers syncytin A and Tfeb were
not affected (Figures 8 and 9). However, muc1, a known direct
transcriptional target of PPARc in trophoblast [10], was
increased 16 fold (P=0.0089) and Gcm1 was increased 1.2 fold
(P=0.03) by rosiglitazone (Figure 9). The effects of rosiglitazone
were PPARc-dependent, as all were absent in PPARc
2/2 TS
cells (Figures 8 and 9). In addition, downregulation of giant cell
markers was not accompanied by changes in the morphologic
assessment of differentiation, as the percentage of giant cells and
syncytiotrophoblast remained the same with or without rosigli-
tazone (data not shown). Finally, rosiglitazone decreased invasion
of differentiated TS cells by 36% in a PPARc-dependent manner
(Figure 7C; P=0.0342).
Introducing PPARc in Genetically Deficient TS Cells
Rescues Syncytiotrophoblastic and Labyrinthine
Differentiation
Since PPARc-null TS cells preferentially and prematurely
differentiate into TGC at the expense of labyrinthine cell
types, and since PPARc activation by rosiglitazone downreg-
ulates markers of TGC while upregulating some labyrinthine
genes, we hypothesized that PPARc promotes labyrinthine/
syncytiotrophoblastic differentiation. To directly test this
hypothesis, we generated an adenoviral construct expressing
a murine PPARc1-HA fusion protein and co-expressing GFP
from an internal ribosome entry site. Western blot verified
formation of an appropriately-sized HA-tagged protein (data
not shown). PPARc-null TS cells were infected with the highly
purified adenovirus; virus expressing only the backbone GFP
construct, without the PPARc1 gene, was used as control. Both
GFP and HA-PPARc1 were detectable in TS cell cultures
Figure 4. PPARc
2/2 TS cells show decreased syncytiotropho-
blastic differentiation. Syncytiotrophoblast (synT) are defined by the
presence of three or more nuclei (identified by blue DAPI fluorescence)
with relatively few actin stress fibers (identified by red phalloidin
fluorescence), while giant cells (TGC) characteristically contained one-
to-two nuclei with highly organized actin stress fibers. The results are
from three independent experiments; for each, 550–600 cells were
counted (*P=0.0227 compared to WT).
doi:10.1371/journal.pone.0008055.g004
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differentiation.
PPARc-expressing virus slowed growth of PPARc-null TS
cells in TSMFH medium (Figure 10A). Also, reintroduction of
PPARc into null cells decreased Matrigel invasion by 44%
(Figure 10B; P=0.0487). When induced to differentiate,
PPARc-virus-infected null cells formed almost twice as many
multi-nucleated syncytiotrophoblast, as control virus-infected
cells (Figure 10C). In addition, by qRT-PCR analysis, Gcm1,
synA, and muc1 expression was induced 1.3–1.5 fold in
differentiated PPARc-virus-infected null TS cells compared to
control virus-infected cells (Figure 11, P,0.05 for each). In
contrast, Tfeb and all giant cell markers were unaffected
(Figure 11, and data not shown). Both WT and PPARc-null TS
cells when differentiated in media containing DMSO, the
carrier used for rosiglitazone, routinely showed more syncy-
tialized cells than did TS cells cultured without DMSO
(compare Figure 10, with DMSO, to Figure 4, without
DMSO). The additional presence of PPARc increased
percentage of syncytiotrophoblast well above and beyond this
DMSO effect; however, rosiglitazone did not further alter
differentiation of PPARc-virus-infected null TS cells as
assessed either by morphology or by qRT-PCR (Figure 10C,
and data not shown).
Discussion
PPARc is expressed at high levels in all placental layers of the
mouse, starting as early as E8.5 (8.5 days post-coitum)
[6 ; Milstone et al., manuscript in preparation]; however, its
role in murine trophoblast differentiation has not been
extensively studied. PPARc-null mice die at midgestation
(E10.5-E11.5) due to abnormalities of the placenta, character-
ized by small labyrinth, reduced spongiotrophoblast, and
expanded giant cell layers [6,7]. To better understand the role
of PPARc in placental development and function, we generated
both wild-type and PPARc-null trophoblast stem (TS) cells and
characterized cellular properties in vitro. We determined that
PPARc-null TS cells show defective differentiation of all three
lineages contributing to labyrinth [19], with decreased expres-
sion of Ctsq (marking sinusoidal TGC after E12.5), syncytin A
(marking syncytiotrophoblast layer I/SynT-I), and Gcm1
(marking syncytiotrophoblast layer II/SynT-II) (Figures 6 and
7A). Instead of forming labyrinth, PPARc-null TS cells
differentiate prematurely and preferentially into trophoblast
giant cells. These observations are consistent with the effects of
PPARc genetic deficiency on placental development in vivo,
particularly the extremely small labyrinth [6,7], and suggest
that PPARc contributes directly to both maintenance of
Figure 5. PPARc
2/2 TS cells show enhanced spongiotrophoblast and giant cell marker expression by quantitative RT-PCR. Note
lower expression of undifferentiated marker, Errb, in PPARc
2/2 TS cells under growth conditions (day 0); along with increased
spongiotrophoblast and giant cell markers, this further emphasizes their premature differentiation under growth conditions. All values are
expressed relative to undifferentiated WT TS cells. *indicates statistically significant (P#0.05) alteration in marker expression in null cells,
compared to WT cells.
doi:10.1371/journal.pone.0008055.g005
PPARc in Trophoblast
PLoS ONE | www.plosone.org 6 November 2009 | Volume 4 | Issue 11 | e8055undifferentiated trophoblast and differentiation of the labyrin-
thine pathway. These results are summarized in the model of
PPARc action in trophoblast differentiation presented in
Figure 12.
Muc1 and PGAR (PPARc angiopoietin related/FIAF/
ANGPTL4) are the only known direct transcriptional targets
of PPARc in placenta [10,22]. Our data show that Gcm1
mRNA expression is induced both by rosiglitazone treatment of
WT (but not null) TS cells (1.2 fold increase, Figure 9) and by
reintroduction of PPARc into null TS cells (1.5 fold increase,
Figure 11). This induction may represent direct transcriptional
regulation by PPARc, as the proximal Gcm1 promoter contains
at least one putative ‘‘atypical’’ PPARc-response element
(PPRE) [23,24 , and data not shown]. Luciferase reporter gene
assays are currently in progress to test PPARc1r e g u l a t i o no f
transcriptional initiation at the proximal murine Gcm1
promoter [23].
The effect of rosiglitazone on downregulation of spongiotro-
phoblast/giant cell markers is consistent with previously
published in vivo data, showing that treatment of pregnant mice
with rosiglitazone downregulates placental Tpbpa expression
and reduces the spongiotrophoblast compartment [11]. We also
observed that rosiglitazone upregulates differentiated TS cell
expression of muc1 (Figure 9), a known direct transcriptional
target of PPARc in labyrinthine trophoblast in vivo [10].
However, while it induced Gcm1 expression, rosiglitazone did
not alter the additional labyrinthine markers syncytin A or Tfeb,
or cause morphologic evidence of syncytiotrophoblastic differ-
entiation in our experiments (Figures 9, 10C, and data not
shown). This induction of some but not all mediators and
consequences of syncytiotrophoblast formation and labyrinthine
differentiation, processes we hypothesize are PPARc-dependent,
could reflect near-maximal PPARc activation by mediators
already present in differentiating TS cell cultures and/or
different roles of PPARc in formation of SynT-I and SynT-II
cells. In addition, although wild type TS cells contribute robustly
to all lineages in vivo, they show limited (only 5–10%) formation of
labyrinthine cell types under the ‘‘standard’’ in vitro differentia-
tion conditions [14,18 , and this paper], [Figure 4]. In contrast,
HIF1b/ARNT-deficient TS cells express high levels of Gcm1
and preferentially differentiate to syncytiotrophoblast in vitro
[17]. Interestingly, differentiated HIF1b/ARNT
2/2 TS cells
also contain high levels of acetylated histone-4, and inhibition of
histone deacetylase in wild type TS cells phenocopies the HIF1b/
ARNT
2/2 mutation [17]. These data suggest that the Gcm1
promoter may be less accessible to transacting factors in cultured
TS cells, due to a condensed chromatin structure, thereby
limiting induction by potential transcriptional regulators, such
as PPARc. Epigenetic effects may thus play a prominent role in
PPARc-dependent trophoblast differentiation and placental
development in vivo but may be incompletely recapitulated by
TS cells differentiating in vitro.
Figure 6. PPARc
2/2 TS cells show decreased labyrinthine markers by quantitative RT-PCR. Note the dramatic decrease in Gcm1, an
essential regulator of labyrinthine differentiation. All values are expressed relative to undifferentiated WT TS cells. *indicates statistically significant
(P#0.05) alteration in marker expression in null cells, compared to WT cells.
doi:10.1371/journal.pone.0008055.g006
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2/2 TS cells showed a 36% decrease in
syncytiotrophoblast, assessed morphologically, compared to
WT cells (4.7% compared to 7.3%; Figure 4). Syncytiotropho-
blast differentiation was also restored (increased 84%) in
PPARc
2/2 TS cells by reintroducing PPARc using adenovirus,
and was not further altered by rosiglitazone (Figure 10).
However, restoring PPARc expression in null cells only
modestly altered labyrinthine marker expression (Figure 11)
and did not alter giant cell markers (data not shown). This
apparent quantitative discrepancy between morphologic and
molecular differentiation may reflect, in part, that only 20–50%
of PPARc
2/2 TS cells were infected by adenovirus (determined
by GFP fluorescence), even at the highest MOI, and only 50%
of these infected cells also showed nuclear localization of
exogenous PPARc (determined by immunofluorescent detec-
tion of HA tag) (Figure 10C and data not shown). Because
syncytiotrophoblast cells were reported as a percent of the cells
showing nuclear localized exogenous PPARc, while mRNA was
(necessarily) quantified in the entire culture, the expression data
underestimates the functional effects of exogenous PPARc, and the
magnitude of the discrepancy is proportional to the fraction of
uninfected cells. In fact, if all infected cells were counted (those
expressing HA-PPARc in the nucleus, the cytoplasm or both), the
percentage of syncytiotrophoblast increased from 8.3% to 11.5%
(38% increase), not to 15.3% (84% increase). However, assessed
either way, the effect of exogenous PPARc on syncytiotrophoblast
differentiation remained statistically significant (P,0.05). In addi-
tion, nuclear HA-PPARc was present in all syncytiotrophoblast
Figure 7. PPARc
2/2 TS cells show altered trophoblast giant cell markers and matrix invasion phenotype. A) Plf expression is
increased and Ctsq expression is decreased in PPARc
2/2 TS cells. *indicates statistically significant (P#0.05) alteration in marker expression in
null cells, compared to WT cells. B) PPARc
2/2 TS cells, differentiated for 7 days, invade Matrigel in greater numbers, compared to their WT
counterparts. Representative images of the underside of Matrigel-coated membrane, following invasion of either WT or PPARc
2/2 TS cells are
shown; invasive cells show characteristic morphology of TGC (blue arrowheads). Small dots (black arrows) correspond to pores in the
membrane. C) Relative invasion of trophoblast in WT and null TS cells with or without rosiglitazone. Note that the effect of rosiglitazone on
trophoblast invasion is PPARc-dependent. *indicates statistically significant (P#0.05) alteration in invasion, compared to WT cells treated with
carrier (DMSO) alone.
doi:10.1371/journal.pone.0008055.g007
PPARc in Trophoblast
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2/2 TS cells rescued by Ad-HA-
PPARc-GFP. This suggests that PPARc supports syncytiotropho-
blast differentiation by regulating activity of a nuclear/transcription
factor(s). This could include upregulation of a factor inducing
labyrinthine differentiation (such as Gcm1) or inhibition of factors
favoring the spongiotrophoblast/giant cell lineage. Finally, en-
hanced giant cell differentiation of PPARc
2/2TS cells may also, in
part reflect unopposed action, and perhaps upregulation of
PPARb/d (see Figure 1D), which is known to induce giant cell
differentiation both in vivo and in vitro [25].
PPARc
2/2 TS cells grew more slowly and showed enhanced
TGC, but not syncytiotrophoblast differentiation in TSMFH
medium relative to their WT counterparts. This suggests that
PPARc
2/2 TSC preferentially differentiate to TGC even under
stem cell conditions (in TSMFH media). Unlike its effect on
syncytiotrophoblast differentiation, reintroducing PPARc into
null cells exacerbated, rather than reversed, the growth
abnormality (Figure 10A). This divergent behavior might reflect
differential sensitivity of growth and differentiation to PPARc
activity. CMV promoter-driven expression from Ad-HA-
PPARc-GFP was 12-fold higher than endogenous PPARc levels
observed in WT TS cell cultures, and was equivalent to levels
normally achieved only after 4 days of differentiation (Figure 1C
and data not shown). This suggests that low level PPARc
expression stabilizes the TS cell undifferentiated state under
growth conditions, while high level expression favors syncytio-
trophoblast formation when differentiation conditions predom-
inate (Figure 12); artificially imposing high level expression in the
absence of differentiation conditions may suppress TS cell
proliferation directly.
In contrast to these defects in labyrinthine trophoblast
development, elevated expression of Plf, Pl-I, and Pl-II, suggests
enhanced differentiation of PPARc
2/2 TS cells into parietal,
canal and spiral artery associated TGCs [19], each of which are
involved in establishing the maternal-fetal interface, analogous
to invasive-type trophoblast in human placenta. Because
PPARc has been implicated in human trophoblast invasion
[8], we analyzed PPARc-null TS cells in Matrigel invasion
assays (Figure 7B). PPARc-null TGC showed enhanced
trophoblast invasion, on a per cell basis, which was reversed
by reintroduction of PPARc (Figure 10B). In addition,
rosiglitazone inhibited trophoblast invasion, in a PPARc-
dependent manner (Figure 7C). This data is consistent with
previous studies showing inhibition of human cytotrophoblast
invasion by PPARc agonists [9].
In summary, the characterization of PPARc-null TS cells has
shed more light on the role of PPARc in trophoblast
differentiation and placental development. The data are
consistent with the in vivo defects of PPARc-deficient placentas
and confirm the utility of cultured TS cells in studies of
placental development. We have shown that PPARc regulates
trophoblast proliferation, invasion, and labyrinthine differenti-
ation, and we hypothesize that these effects are mediated, at
least partially, through Gcm1. More extensive gene expression
Figure 8. Rosiglitazone, a PPARc agonist, downregulates giant cell markers in a PPARc-dependent manner. *indicates statistically
significant alteration in marker expression between the indicated conditions.
doi:10.1371/journal.pone.0008055.g008
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further identify potential downstream targets of PPARc in
trophoblast differentiation. These studies will help elucidate the
role of PPARc in placental development and determine the
utility of specific agonists in treatment of placenta-related
pregnancy disorders.
Materials and Methods
Ethics Statement
All animal work was approved by, and conducted according to
the guidelines of, the Institutional Animal Care and Use
Committee at Brigham and Women’s Hospital.
Derivation and Culture of TS Cells
PPARc
+/+ and PPARc
2/2 TS cells were derived from E3.5
blastocysts from PPARc
+/26PPARc
+/2 matings of mice with
mixed (C57Bl/6J:129:FVB) genetic background [26,27], on
murine embryonic feeder cells (MEF), and cultured as
previously described [14]. For feeder-free cultures, TS cells
without MEF were grown in 30% TS cell medium (TS
medium), 70% MEF-conditioned (72 h) TS medium, 25 mg/ml
FGF4 (Sigma), and 1 mg/ml heparin (Sigma) (TSMFH
medium). TS cells grown to confluence in TSMFH medium
were switched to TS medium to induce differentiation.
All cells were cultured at 37uC under 95% room air and 5%
CO2.
Morphologic Analysis of Differentiation
TS cells were cultured as described above, on glass coverslips.
Cells were fixed in 2% paraformaldehyde in PBS for 15 minutes
and permeabilized in 0.02% Triton X-100 in PBS for 2 minutes.
Mouse anti-HA tag antibody (Abcam) and Alexa dye-conjugated
phalloidin and secondary antibodies (Molecular Probes) were
used per manufacturer’s instructions. Coverslips were mounted
using Vectashield mounting media containing DAPI (Vector
labs). Trophoblast giant cells were identified by large single or
double nuclei, each at least twice the size (judged as estimated
cross-sectional area) of an undifferentiated TS cell nucleus;
syncytiotrophoblast were identified as cells with 3 or more nuclei,
each of which were similar in size to an undifferentiated TS cell
nucleus.
Proliferation and Invasion Assays
Cell proliferation was assayed using the MTT Cell Proliferation
Kit I (Roche), with cells plated in 96-well plates at an initial density
of 5610
3 cells per well. Five replicate wells were assayed for each
condition and/or time point.
Matrigel invasion assays were done as described previously [21]
with the following modifications. Cells were differentiated for 7
days in TS media; on day 7, cells were trypsinized and plated onto
the Matrigel at a concentration of 10
5 cells per insert. The media
in the lower chamber was changed every day. After 3 days, the
Transwell inserts were fixed for 15 minutes with 3.7% formalde-
hyde in PBS and washed with PBS. Cells that remained at the
upper surface of the filters were scraped off and filters were stained
Figure 9. Rosiglitazone, a PPARc agonist, upregulates select labyrinthine markers in a PPARc-dependent manner. *indicates
statistically significant alteration in marker expression between the indicated conditions.
doi:10.1371/journal.pone.0008055.g009
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bottom of the filter) were imaged and counted using a light
microscope (Leica).
RNA Isolation and Quantitative Reverse Transcription-
PCR (qRT-PCR)
DNase-treated total RNA was isolated using NucleoSpin
RNA II kit (Clontech). cDNA was prepared from 1 mgR N A
using iScript (Bio-Rad) in a 20 ml reaction, and diluted 1:5 with
nuclease-free water. PCR was performed using 4 mlo ft h e
diluted cDNA, along with 625 nM of each primer and
POWER SYBR Green PCR master mix (Applied Biosystems)
in a total reaction volume of 20 ml. qRT-PCR was performed
using a System 7300 instrument (Applied Biosystems) and a
one-step program: 95uC, 10 min; 95uC, 30 s, 60uC, 1 min, for
40 cycles. Unless otherwise stated, each experiment was
performed in triplicate, and all results were normalized against
18S rRNA. Relative mRNA expression levels, compared to
18S rRNA, were determined by the DDCT method [28]. Fold
change in normalized expression of individual genes in
experimental samples was determined by comparison to
expression in undifferentiated PPARc
+/+ cells. All primer
pairs (Table 1) were checked for specificity using BLAST
analysis and were checked by both agarose gel electrophoresis
and thermal dissociation curves to ensure amplification of
as i n g l ep r o d u c tw i t ht h ea p p r o p r i a t es i z ea n dm e l t i n g
temperature.
Whole Cell Lysate Preparation and Western Blotting
Cells were washed with cold 1X PBS and lysates were
prepared by scraping cells in boiled 1X Laemmli sample buffer
(Bio-Rad), and passing the lysate through a 25G needle to sheer
DNA and decrease viscosity. Protein determination was done
using a Coomassie-binding assay [29]. For Western blot, 20 mg
of total protein was loaded in each lane. After transfer to PVDF,
the membranes were blocked with 5% non-fat dried milk in
TBS-Tween for 1 hour at room temperature. Primary and
secondary antibody incubations were similarly performed, with
antibodies diluted in blocking buffer per the manufacturer’s
recommendation. Antibodies used included mouse anti-PPARc
monoclonal antibody and rabbit polyclonal antibodies against
PPARa and PPARb (all three from Santa Cruz Biotechnology,
Inc.), mouse anti-actin monoclonal antibody (Abcam) used as
loading control, and HRP-conjugated secondary antibodies
(Jackson Immunochemicals). After treatment with ECL reagent
(Pierce), membranes were exposed to autoradiography film
(Kodak). Expression was quantified by densitometric scanning
followed by normalizing PPARc, PPARa and PPARb/d
expression to that of b-actin.
Generation of Adenovirus and Transduction of TS Cells
Full length murine PPARc1c D N Aw a so b t a i n e db yR T - P C R
from E10.5 placental RNA, confirmed by sequence analysis,
and cloned into pShuttle-IRES-hrGFP-2 adenoviral vector
(Stratagene), in order to generate a hemagglutinin (HA)-tagged
Figure 10. Effects of reintroducing PPARc into PPARc
2/2 TS cells. A) PPARc overexpression in undifferentiated null TS cells further inhibits
cell growth. B) Reintroduction of PPARc into PPARc
2/2 TS cells decreases trophoblast invasion. *P,0.05. C) Morphologic assessment of cellular
differentiation in null TS cells infected with either GFP-expressing adenovirus, or adenovirus expressing HA-tagged PPARc1. Images are representative
of cells infected with either GFP-expressing adenovirus (left) or HA-tagged PPARc (right), with nuclei counterstained with DAPI. Cell counts are from
three independent experiments (* P,0.05 compared to pAd-GFP-infected cells).
doi:10.1371/journal.pone.0008055.g010
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PLoS ONE | www.plosone.org 11 November 2009 | Volume 4 | Issue 11 | e8055Figure 11. Labyrinthine marker assessment in null TS cells infected with either GFP- or PPARc-expressing adenovirus. Gcm1, muc1,
and SynA, but not Tfeb, are increased in PPARc-virus-infected null cells. White columns indicate values for an aliquot of the
same undifferentiated PPARc
2/2 TS cells used for transduction but not exposed to virus. *indicates P,0.05 compared to pAd-GFP-infected cells.
doi:10.1371/journal.pone.0008055.g011
Figure 12. Model of PPARc’s role in trophoblast differentiation. Note that PPARc contributes to both maintenance of undifferentiated
trophoblast (by inhibiting premature differentiation) and differentiation towards the labyrinthine lineages. Errb
+ cells denote undifferentiated TS cells;
FGF4/CM refers to the presence of FGF4 and MEF-conditioned media, both of which are required for maintenance of the undifferentiated state. The
spongiotrophoblast (Tpbpa
+ giant cell precursor) and trophoblast giant cell (Pl-I
+, Pl-II
+, Plf
+) lineages are distinguished from labyrinthine precursor
(Tpbpa
2) cells as well as fully differentiated labyrinthine cells (synA
+ SynT-I, Gcm1
+ SynT-II, and Ctsq
+ mononuclear cells).
doi:10.1371/journal.pone.0008055.g012
PPARc in Trophoblast
PLoS ONE | www.plosone.org 12 November 2009 | Volume 4 | Issue 11 | e8055protein (HA-PPARc) co-expressed with GFP. This construct
w a su s e dt og e n e r a t ea d e n o v i r u su s i n gt h eA d E a s yX Ls y s t e m
(Invitrogen). Large-scale production of adenovirus was accom-
plished by infecting subconfluent 293A cells (Invitrogen) with
the crude viral lysate in 15-cm tissue culture dishes. Virus was
purified by CsCl gradient centrifugation, desalted by chroma-
tography on PD-10 columns (Amersham), and stored in 10%
glycerol in PBS at 280uC. Titers were determined by plaque
assay using 293A cells, according to Invitrogen’s Virapower
Adenoviral Expression System protocol. TS cells were infected
with this purified virus, at an MOI of 10–50, in growth media
(TSMFH media: 70% MEF-conditioned medium, with FGF4
and heparin); the day after infection, cells were switched to
differentiation media (TS media only) and cultured an
additional 1–7 days before harvesting. Expression of HA-
PPARc from this adenovirus was confirmed by both immuno-
fluorescence and Western blot using an anti-HA tag antibody
(Abcam). On average, this protocol resulted in infection of 20–
50% of TS cells.
Statistical Analysis
Unless otherwise stated, data presented are mean 6 standard
deviation of three replicate wells of a single prep of cells; the
results shown are representative of 3–5 separate experiments
each performed on different days and using a different
preparation of cells. Student’s t-test was performed and a P
value of 0.05 was taken to indicate a statistically significant
difference between the populations sampled. Standard devia-
tions are illustrated in all figures, but in some cases are too small
to observe.
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